{"transactions":[{"id":772156,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-19T20:25:29.000Z","date":"2026-05-15","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-third of the shares underlying the option will vest on June 21, 2024; thereafter, one-third of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":21501,"derivative":{"exercise_price":16.75,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001470831-26-000470","document":"wk-form4_1779222325.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000470/wk-form4_1779222325.xml","form_type":"4"}},{"id":772155,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-19T20:25:29.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":200,"price":69.12,"value":13824.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025."}],"balance_after":11589,"source":{"system":"sec-edgar","filing":"0001470831-26-000470","document":"wk-form4_1779222325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000470/wk-form4_1779222325.xml","form_type":"4"}},{"id":772154,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-19T20:25:29.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":1512,"price":68.2303,"value":103164.2136,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold from $68.10 to $68.40 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":11789,"source":{"system":"sec-edgar","filing":"0001470831-26-000470","document":"wk-form4_1779222325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000470/wk-form4_1779222325.xml","form_type":"4"}},{"id":772153,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-19T20:25:29.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":2088,"price":67.5302,"value":141003.0576,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold from $67.10 to $68.09 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":13301,"source":{"system":"sec-edgar","filing":"0001470831-26-000470","document":"wk-form4_1779222325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000470/wk-form4_1779222325.xml","form_type":"4"}},{"id":772152,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-19T20:25:29.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":6200,"price":66.6878,"value":413464.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $66.08 to $67.07 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":15389,"source":{"system":"sec-edgar","filing":"0001470831-26-000470","document":"wk-form4_1779222325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000470/wk-form4_1779222325.xml","form_type":"4"}},{"id":772151,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-19T20:25:29.000Z","date":"2026-05-15","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":16.75,"value":167500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025."}],"balance_after":21589,"source":{"system":"sec-edgar","filing":"0001470831-26-000470","document":"wk-form4_1779222325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000470/wk-form4_1779222325.xml","form_type":"4"}},{"id":896954,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-18T23:34:13.000Z","date":"2026-02-17","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/3rd of the shares underlying the option will vest on June 21, 2024; thereafter, 1/3rd of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":31501,"derivative":{"exercise_price":16.75,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001470831-26-000182","document":"wk-form4_1771457650.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000182/wk-form4_1771457650.xml","form_type":"4"}},{"id":896953,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-18T23:34:13.000Z","date":"2026-02-17","kind":"sale","planned":true,"acquired":false,"shares":3307,"price":75.9261,"value":251087.6127,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold from $75.82 to $76.23 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":11589,"source":{"system":"sec-edgar","filing":"0001470831-26-000182","document":"wk-form4_1771457650.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000182/wk-form4_1771457650.xml","form_type":"4"}},{"id":896952,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-18T23:34:13.000Z","date":"2026-02-17","kind":"sale","planned":true,"acquired":false,"shares":4793,"price":75.5725,"value":362218.9925,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold from $74.82 to $75.815 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":14896,"source":{"system":"sec-edgar","filing":"0001470831-26-000182","document":"wk-form4_1771457650.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000182/wk-form4_1771457650.xml","form_type":"4"}},{"id":896951,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-18T23:34:13.000Z","date":"2026-02-17","kind":"sale","planned":true,"acquired":false,"shares":1900,"price":74.3421,"value":141249.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $73.74 to $74.67 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":19689,"source":{"system":"sec-edgar","filing":"0001470831-26-000182","document":"wk-form4_1771457650.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000182/wk-form4_1771457650.xml","form_type":"4"}},{"id":896950,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-18T23:34:13.000Z","date":"2026-02-17","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":16.75,"value":167500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025."}],"balance_after":21589,"source":{"system":"sec-edgar","filing":"0001470831-26-000182","document":"wk-form4_1771457650.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083126000182/wk-form4_1771457650.xml","form_type":"4"}},{"id":993884,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-19T22:06:52.000Z","date":"2025-11-17","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third of the shares underlying the option vested on June 21, 2024; thereafter, one-third of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the Reporting Person's continued service on the board of directors of the Issuer."}],"balance_after":41501,"derivative":{"exercise_price":16.75,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001470831-25-000355","document":"wk-form4_1763590009.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083125000355/wk-form4_1763590009.xml","form_type":"4"}},{"id":993883,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-19T22:06:52.000Z","date":"2025-11-17","kind":"sale","planned":true,"acquired":false,"shares":6199,"price":66.8908,"value":414656.0692,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold from $66.65 to $67.48 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":11589,"source":{"system":"sec-edgar","filing":"0001470831-25-000355","document":"wk-form4_1763590009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083125000355/wk-form4_1763590009.xml","form_type":"4"}},{"id":993882,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-19T22:06:52.000Z","date":"2025-11-17","kind":"sale","planned":true,"acquired":false,"shares":3801,"price":66.2481,"value":251809.0281,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $65.64 to $66.63 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":17788,"source":{"system":"sec-edgar","filing":"0001470831-25-000355","document":"wk-form4_1763590009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083125000355/wk-form4_1763590009.xml","form_type":"4"}},{"id":993881,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-19T22:06:52.000Z","date":"2025-11-17","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":16.75,"value":167500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025."}],"balance_after":21589,"source":{"system":"sec-edgar","filing":"0001470831-25-000355","document":"wk-form4_1763590009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000147083125000355/wk-form4_1763590009.xml","form_type":"4"}},{"id":1102681,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T22:54:29.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":8425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the shares underlying the stock option will vest each year after June 20, 2025, such that all of the underlying shares will be vested on June 20, 2028, subject to the Reporting Person's continued service on the Issuer's board of directors."}],"balance_after":8425,"derivative":{"exercise_price":41.73,"expiration_date":"2035-06-19","underlying":"Common Stock","underlying_shares":8425},"source":{"system":"sec-edgar","filing":"0000950170-25-089642","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000095017025089642/ownership.xml","form_type":"4"}},{"id":1102680,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T22:54:29.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":6589,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted stock units (\"RSUs\") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan.  One-third of the RSUs will vest each year after June 20, 2025, such that all of the units will be vested on June 20, 2028, subject to the Reporting Person's continued service on the Issuer's board of directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":11589,"source":{"system":"sec-edgar","filing":"0000950170-25-089642","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000095017025089642/ownership.xml","form_type":"4"}},{"id":1469561,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-25T21:42:09.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":26014,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares underlying the stock option will vest each year after June 21, 2024, such that all of the underlying shares will be vested on June 21, 2027, subject to the Reporting Person's continued service on the board of directors of the Issuer."}],"balance_after":26014,"derivative":{"exercise_price":27.36,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":26014},"source":{"system":"sec-edgar","filing":"0000950170-24-077452","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000095017024077452/ownership.xml","form_type":"4"}},{"id":1490115,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-05T20:53:19.000Z","date":"2024-06-04","kind":"sale","planned":true,"acquired":false,"shares":1500,"price":31.3,"value":46950.0,"ownership":{"direct":false,"nature":"By Thinking Bench Capital LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by Thinking Bench Capital LLC on June 6, 2023."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0000950170-24-069401","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000095017024069401/ownership.xml","form_type":"4"}},{"id":1490114,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-05T20:53:19.000Z","date":"2024-06-03","kind":"sale","planned":true,"acquired":false,"shares":200,"price":29.475,"value":5895.0,"ownership":{"direct":false,"nature":"By Thinking Bench Capital LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by Thinking Bench Capital LLC on June 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $29.44 to $29.55 per share.  The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":5500,"source":{"system":"sec-edgar","filing":"0000950170-24-069401","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000095017024069401/ownership.xml","form_type":"4"}},{"id":1490113,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-05T20:53:19.000Z","date":"2024-06-03","kind":"sale","planned":true,"acquired":false,"shares":800,"price":28.6844,"value":22947.52,"ownership":{"direct":false,"nature":"By Thinking Bench Capital LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by Thinking Bench Capital LLC on June 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $28.31 to $29.24 per share.  The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":5700,"source":{"system":"sec-edgar","filing":"0000950170-24-069401","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000095017024069401/ownership.xml","form_type":"4"}},{"id":1596735,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-05T21:00:11.000Z","date":"2024-03-01","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":34,"value":85000.0,"ownership":{"direct":false,"nature":"By Thinking Bench Capital LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by Thinking Bench Capital LLC on June 6, 2023."}],"balance_after":6500,"source":{"system":"sec-edgar","filing":"0000950170-24-025839","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000095017024025839/ownership.xml","form_type":"4"}},{"id":1703396,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-20T21:00:06.000Z","date":"2023-12-18","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":40,"value":80000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by Thinking Bench Capital LLC on June 6, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"By Thinking Bench Capital LLC."}],"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001209191-23-059324","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000120919123059324/doc4.xml","form_type":"4"}},{"id":1721822,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-05T21:00:09.000Z","date":"2023-12-01","kind":"sale","planned":true,"acquired":false,"shares":1500,"price":30,"value":45000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by Thinking Bench Capital LLC on June 6, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"By Thinking Bench Capital LLC."}],"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001209191-23-057374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000120919123057374/doc4.xml","form_type":"4"}},{"id":1721821,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-05T21:00:09.000Z","date":"2023-12-01","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":28.5,"value":28500.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by Thinking Bench Capital LLC on June 6, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"By Thinking Bench Capital LLC."}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001209191-23-057374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000120919123057374/doc4.xml","form_type":"4"}},{"id":1785910,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-07T20:00:09.000Z","date":"2023-09-05","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":30,"value":75000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by Thinking Bench Capital LLC on June 6, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"By Thinking Bench Capital LLC."}],"balance_after":13500,"source":{"system":"sec-edgar","filing":"0001209191-23-048595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000120919123048595/doc4.xml","form_type":"4"}},{"id":1845287,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T20:24:15.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":51501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the shares underlying the option will vest on June 21, 2024; thereafter, 1/3rd of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":51501,"derivative":{"exercise_price":16.75,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":51501},"source":{"system":"sec-edgar","filing":"0001209191-23-039393","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000120919123039393/doc4.xml","form_type":"4"}},{"id":1858483,"issuer":{"id":87664,"kind":"organization","name":"Talis Biomedical Corp","symbol":"TLIS"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-06-12T21:29:36.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest monthly over one year from the vesting commencement date."}],"balance_after":95000,"derivative":{"exercise_price":0.5,"expiration_date":"2033-06-09","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001209191-23-036409","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000120919123036409/doc4.xml","form_type":"4"}},{"id":1910025,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-01T20:20:23.000Z","date":"2023-04-27","kind":"grant","planned":false,"acquired":true,"shares":86705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents Board Chair Compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests in twelve equal monthly installments starting from April 27, 2023, subject to continued service with the Issuer through the applicable vesting dates."}],"balance_after":86705,"derivative":{"exercise_price":1.36,"expiration_date":"2033-04-27","underlying":"Common Stock","underlying_shares":86705},"source":{"system":"sec-edgar","filing":"0000899243-23-011937","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000089924323011937/doc4.xml","form_type":"4"}},{"id":1910024,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-01T20:20:23.000Z","date":"2023-04-27","kind":"grant","planned":false,"acquired":true,"shares":28901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests in twelve equal monthly installments starting from April 27, 2023, subject to continued service with the Issuer through the applicable vesting dates."}],"balance_after":28901,"derivative":{"exercise_price":1.36,"expiration_date":"2033-04-27","underlying":"Common Stock","underlying_shares":28901},"source":{"system":"sec-edgar","filing":"0000899243-23-011937","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000089924323011937/doc4.xml","form_type":"4"}},{"id":1910023,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-01T20:20:23.000Z","date":"2023-04-27","kind":"grant","planned":false,"acquired":true,"shares":70422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issuable upon settlement of a restricted stock unit award that vests in full on May 15, 2024, subject to continued service with the Issuer through the vesting date."}],"balance_after":161222,"source":{"system":"sec-edgar","filing":"0000899243-23-011937","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000089924323011937/doc4.xml","form_type":"4"}},{"id":2205129,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-07-19T22:48:18.000Z","date":"2022-07-16","kind":"grant","acquired":true,"shares":4275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option vests in nine equal monthly installments starting from July 16, 2022."}],"balance_after":4275,"derivative":{"exercise_price":2.85,"expiration_date":"2032-07-16","underlying":"Common Stock","underlying_shares":4275},"source":{"system":"sec-edgar","filing":"0000899243-22-026378","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000089924322026378/doc4.xml","form_type":"4"}},{"id":2205128,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-07-19T22:48:18.000Z","date":"2022-07-16","kind":"grant","acquired":true,"shares":22730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests over four years, with 25% of the shares vesting on July 16, 2023, and 1/48th of the remaining shares vesting monthly thereafter for the remaining three years."}],"balance_after":22730,"derivative":{"exercise_price":2.85,"expiration_date":"2032-07-16","underlying":"Common Stock","underlying_shares":22730},"source":{"system":"sec-edgar","filing":"0000899243-22-026378","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000089924322026378/doc4.xml","form_type":"4"}},{"id":2205127,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-19T22:48:18.000Z","date":"2022-07-16","kind":"grant","acquired":true,"shares":8475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares issuable upon settlement of a restricted stock unit award that vests in full on May 15, 2023."}],"balance_after":90800,"source":{"system":"sec-edgar","filing":"0000899243-22-026378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000089924322026378/doc4.xml","form_type":"4"}},{"id":2205126,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-19T22:48:18.000Z","date":"2022-07-16","kind":"grant","acquired":true,"shares":45325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issuable upon settlement of a restricted stock unit award that vests in four equal installments, with 1/4th of the total award vesting on each of August 15, 2023, 2024, 2025 and 2026, subject to continued service with the issuer through the applicable vesting dates."}],"balance_after":82325,"source":{"system":"sec-edgar","filing":"0000899243-22-026378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000089924322026378/doc4.xml","form_type":"4"}},{"id":2222117,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T20:37:23.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":104921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the shares underlying the option will vest on June 22, 2023; thereafter, 1/3rd of the remaining underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on the June 22, 2025, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":104921,"derivative":{"exercise_price":8.45,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":104921},"source":{"system":"sec-edgar","filing":"0001209191-22-039268","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000120919122039268/doc4.xml","form_type":"4"}},{"id":2233796,"issuer":{"id":87664,"kind":"organization","name":"Talis Biomedical Corp","symbol":"TLIS"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-13T21:41:57.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest monthly over one year from the vesting commencement date."}],"balance_after":95000,"derivative":{"exercise_price":1,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001209191-22-036427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000120919122036427/doc4.xml","form_type":"4"}},{"id":2658953,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-22T22:47:41.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":38895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in three annual installments after June 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date."}],"balance_after":38895,"derivative":{"exercise_price":62.63,"expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":38895},"source":{"system":"sec-edgar","filing":"0000899243-21-025362","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924321025362/doc4.xml","form_type":"4"}},{"id":2707419,"issuer":{"id":87664,"kind":"organization","name":"Talis Biomedical Corp","symbol":"TLIS"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2021-05-18T19:19:03.000Z","date":"2021-05-17","kind":"purchase","acquired":true,"shares":11000,"price":10.11,"value":111210.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This purchase was executed in multiple purchases at prices ranging from $10.00 to $10.15. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-21-033441","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000120919121033441/doc4.xml","form_type":"4"}},{"id":2707418,"issuer":{"id":87664,"kind":"organization","name":"Talis Biomedical Corp","symbol":"TLIS"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2021-05-18T19:19:03.000Z","date":"2021-05-14","kind":"purchase","acquired":true,"shares":9000,"price":10.16,"value":91440.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This purchase was executed in multiple purchases at prices ranging from $10.03 to $10.25. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001209191-21-033441","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000120919121033441/doc4.xml","form_type":"4"}},{"id":2845725,"issuer":{"id":87664,"kind":"organization","name":"Talis Biomedical Corp","symbol":"TLIS"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series F-1 Preferred Stock","published_at":"2021-02-19T23:18:21.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":432749,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Thinking Bench Capital, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of Series F-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series F-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series F-1 Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Series F-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series F-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series F-1 Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Series F-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series F-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series F-1 Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Thinking Bench Capital, LLC, for which Dr. Scott is the manager. The OG Family Trust, u/d/t May 30, 2014 is the sole member of Thinking Bench Capital, LLC. Dr. Scott and his spouse are trustees and share voting and dispositive power of the OG Family Trust, u/d/t May 30, 2014."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":302621},"source":{"system":"sec-edgar","filing":"0001209191-21-012519","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000120919121012519/doc4.xml","form_type":"4"}},{"id":2845724,"issuer":{"id":87664,"kind":"organization","name":"Talis Biomedical Corp","symbol":"TLIS"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series E-1 Preferred Stock","published_at":"2021-02-19T23:18:21.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":478402,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Thinking Bench Capital, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series E-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series E-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series E-1 Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series E-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series E-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series E-1 Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series E-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series E-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series E-1 Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Thinking Bench Capital, LLC, for which Dr. Scott is the manager. The OG Family Trust, u/d/t May 30, 2014 is the sole member of Thinking Bench Capital, LLC. Dr. Scott and his spouse are trustees and share voting and dispositive power of the OG Family Trust, u/d/t May 30, 2014."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":334546},"source":{"system":"sec-edgar","filing":"0001209191-21-012519","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000120919121012519/doc4.xml","form_type":"4"}},{"id":2845723,"issuer":{"id":87664,"kind":"organization","name":"Talis Biomedical Corp","symbol":"TLIS"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D-1 Preferred Stock","published_at":"2021-02-19T23:18:21.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":1076643,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Thinking Bench Capital, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series D-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series D-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series D-1 Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series D-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series D-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series D-1 Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series D-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series D-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series D-1 Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Thinking Bench Capital, LLC, for which Dr. Scott is the manager. The OG Family Trust, u/d/t May 30, 2014 is the sole member of Thinking Bench Capital, LLC. Dr. Scott and his spouse are trustees and share voting and dispositive power of the OG Family Trust, u/d/t May 30, 2014."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":752897},"source":{"system":"sec-edgar","filing":"0001209191-21-012519","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000120919121012519/doc4.xml","form_type":"4"}},{"id":2845722,"issuer":{"id":87664,"kind":"organization","name":"Talis Biomedical Corp","symbol":"TLIS"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T23:18:21.000Z","date":"2021-02-17","kind":"purchase","acquired":true,"shares":312500,"price":16,"value":5000000.0,"ownership":{"direct":false,"nature":"By OG Family Trust, u/d/t May 30, 2014"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held directly by the OG Family Trust, u/d/t May 30, 2014. Dr. Scott and his spouse are trustees and share voting and dispositive power over the shares held by OG Family Trust, u/d/t May 30, 2014."}],"balance_after":312500,"source":{"system":"sec-edgar","filing":"0001209191-21-012519","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000120919121012519/doc4.xml","form_type":"4"}},{"id":2845721,"issuer":{"id":87664,"kind":"organization","name":"Talis Biomedical Corp","symbol":"TLIS"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T23:18:21.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":302621,"ownership":{"direct":false,"nature":"By Thinking Bench Capital, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Series F-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series F-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series F-1 Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Thinking Bench Capital, LLC, for which Dr. Scott is the manager. The OG Family Trust, u/d/t May 30, 2014 is the sole member of Thinking Bench Capital, LLC. Dr. Scott and his spouse are trustees and share voting and dispositive power of the OG Family Trust, u/d/t May 30, 2014."}],"balance_after":1390064,"source":{"system":"sec-edgar","filing":"0001209191-21-012519","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000120919121012519/doc4.xml","form_type":"4"}},{"id":2845720,"issuer":{"id":87664,"kind":"organization","name":"Talis Biomedical Corp","symbol":"TLIS"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T23:18:21.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":334546,"ownership":{"direct":false,"nature":"By Thinking Bench Capital, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series E-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series E-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series E-1 Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Thinking Bench Capital, LLC, for which Dr. Scott is the manager. The OG Family Trust, u/d/t May 30, 2014 is the sole member of Thinking Bench Capital, LLC. Dr. Scott and his spouse are trustees and share voting and dispositive power of the OG Family Trust, u/d/t May 30, 2014."}],"balance_after":1087443,"source":{"system":"sec-edgar","filing":"0001209191-21-012519","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000120919121012519/doc4.xml","form_type":"4"}},{"id":2845719,"issuer":{"id":87664,"kind":"organization","name":"Talis Biomedical Corp","symbol":"TLIS"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T23:18:21.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":752897,"ownership":{"direct":false,"nature":"By Thinking Bench Capital, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series D-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series D-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series D-1 Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Thinking Bench Capital, LLC, for which Dr. Scott is the manager. The OG Family Trust, u/d/t May 30, 2014 is the sole member of Thinking Bench Capital, LLC. Dr. Scott and his spouse are trustees and share voting and dispositive power of the OG Family Trust, u/d/t May 30, 2014."}],"balance_after":752897,"source":{"system":"sec-edgar","filing":"0001209191-21-012519","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000120919121012519/doc4.xml","form_type":"4"}},{"id":2850533,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-18T23:21:05.000Z","date":"2021-02-17","kind":"purchase","acquired":true,"shares":16000,"price":62.5,"value":1000000.0,"ownership":{"direct":true},"balance_after":21000,"source":{"system":"sec-edgar","filing":"0000899243-21-007172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924321007172/doc4.xml","form_type":"4"}},{"id":3099868,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-25T20:41:41.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":101223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest and become exercisable in three annual installments after June 23, 2020, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":101223,"derivative":{"exercise_price":32.62,"expiration_date":"2030-06-22","underlying":"Common Stock","underlying_shares":101223},"source":{"system":"sec-edgar","filing":"0000899243-20-017667","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743881/000089924320017667/doc4.xml","form_type":"4"}},{"id":3427933,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2019-08-27T23:18:12.000Z","date":"2019-08-26","kind":"sale","acquired":false,"shares":28301,"price":24.8198,"value":702425.1598,"ownership":{"direct":false,"nature":"By OG Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 10, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sale price. Actual sale prices ranged from $24.61 to $25.00."}],"balance_after":3450669,"source":{"system":"sec-edgar","filing":"0000899243-19-022539","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000089924319022539/doc4.xml","form_type":"4"}},{"id":3427932,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2019-08-27T23:18:12.000Z","date":"2019-08-26","kind":"sale","acquired":false,"shares":11699,"price":24.0174,"value":280979.5626,"ownership":{"direct":false,"nature":"By OG Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 10, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sale price. Actual sale prices ranged from $23.61 to $24.59."}],"balance_after":3478970,"source":{"system":"sec-edgar","filing":"0000899243-19-022539","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000089924319022539/doc4.xml","form_type":"4"}},{"id":3507283,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2019-05-30T23:23:21.000Z","date":"2019-05-28","kind":"sale","acquired":false,"shares":30000,"price":17.6009,"value":528027.0,"ownership":{"direct":false,"nature":"By OG Family Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 10, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sale price. Actual sale prices ranged from $17.400 to $17.845."}],"balance_after":3490669,"source":{"system":"sec-edgar","filing":"0000899243-19-015216","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000089924319015216/doc4.xml","form_type":"4"}},{"id":3537772,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (right to buy)","published_at":"2019-05-06T23:14:19.000Z","date":"2019-05-02","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve equal monthly installments starting from May 2, 2019."}],"balance_after":10000,"derivative":{"exercise_price":24.16,"expiration_date":"2029-05-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-19-012327","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000089924319012327/doc4.xml","form_type":"4"}},{"id":3628639,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2019-02-27T19:13:18.000Z","date":"2019-02-25","kind":"sale","acquired":false,"shares":1000,"price":19.657,"value":19657.0,"ownership":{"direct":false,"nature":"By OG Family Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 10, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sale price. Actual sale prices ranged from $19.60 to $19.77."}],"balance_after":3520669,"source":{"system":"sec-edgar","filing":"0000899243-19-004961","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000089924319004961/doc4.xml","form_type":"4"}},{"id":3628638,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2019-02-27T19:13:18.000Z","date":"2019-02-25","kind":"sale","acquired":false,"shares":29000,"price":19.0807,"value":553340.3,"ownership":{"direct":false,"nature":"By OG Family Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 10, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sale price. Actual sale prices ranged from $18.58 to $19.57."}],"balance_after":3521669,"source":{"system":"sec-edgar","filing":"0000899243-19-004961","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000089924319004961/doc4.xml","form_type":"4"}},{"id":3883864,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-06-26T00:48:46.000Z","date":"2018-06-22","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve equal monthly installments starting from June 22, 2018."}],"balance_after":10000,"derivative":{"exercise_price":8.08,"expiration_date":"2028-06-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-18-018014","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000089924318018014/doc4.xml","form_type":"4"}},{"id":3976078,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-04-02T20:05:28.000Z","date":"2018-04-02","kind":"purchase","acquired":true,"shares":44444,"price":4.5,"value":199998.0,"ownership":{"direct":false,"nature":"Randall W. Scott and Eileen M. Scott, Trustees of the OG Family Trust"},"balance_after":3550669,"source":{"system":"sec-edgar","filing":"0000899243-18-009049","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000089924318009049/doc4.xml","form_type":"4"}},{"id":4333095,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-05-04T20:52:20.000Z","date":"2017-05-02","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve equal monthly installments beginning on May 2, 2017."}],"balance_after":10000,"derivative":{"exercise_price":11.13,"expiration_date":"2027-05-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-17-011849","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000089924317011849/doc4.xml","form_type":"4"}},{"id":4544649,"issuer":{"id":95935,"kind":"organization","name":"Invitae Corp","symbol":"NVTA"},"owners":[{"id":28579,"kind":"person","name":"Scott Randal W.","position":1,"cik":"0001337801","reported_name":"Scott Randal W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2016-11-22T23:07:09.000Z","date":"2016-11-22","kind":"purchase","acquired":true,"shares":66666,"price":6,"value":399996.0,"ownership":{"direct":true},"balance_after":3506225,"source":{"system":"sec-edgar","filing":"0000899243-16-034175","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337801/000089924316034175/doc4.xml","form_type":"4"}}]}